News

Cardiac involvement is the principal determinant of prognosis in light-chain (AL) amyloidosis. B-type natriuretic peptide (BNP) and N-terminal pro-B-type…

Significant gaps remain in diagnosing hereditary transthyretin amyloidosis (hATTR) within the Black population, a new study in the Journal of Community Genetics…

Measuring blood levels of a protein called neurofilament light chain (NfL) may help identify nerve damage in people with hereditary transthyretin amyloidosis with…

DelveInsight's "Cardiac Amyloidosis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Cardiac Amyloidosis,…

ROLE SUMMARYThe Medical Engagement, Strategy & Insights Director provides senior scientific and medical expertise in Transthyretin Amyloid Cardiomyopathy (ATTR-…

Scientific Frontline: Extended "At a Glance" Summary: Hereditary ATTR Amyloidosis and Redox ImbalanceThe Core Concept: Hereditary ATTR amyloidosis is a progressive…

AbstractBackgroundVal142Ile hereditary transthyretin amyloidosis (hATTR) is an underrecognized cause of heart failure with preserved ejection fraction (HFpEF) in…

AbstractHereditary transthyretin amyloidosis (ATTRv) is a progressive, life-threatening disease caused by mutations in the TTR gene. It is characterized by marked…

AbstractTransthyretin cardiac amyloidosis (ATTR-CM) is an increasingly recognized infiltrative cardiomyopathy characterized by progressive myocardial amyloid…

Immunoglobulin light chain (AL) amyloidosis and POEMS syndrome are plasma cell proliferative disorders involving multiple organs and tissues, often presenting with…